Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leu
Link ID 12223
Title Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leu
Url http://www.medscape.com/viewarticle/584602?src=rss
Description New cases, the survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy, and the characteristics of PML-associated immune reconstitution inflammatory syndrome are analyzed.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Category Articles > HIV/AIDS
Keywords
Date Jan 7, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. Long-term Safety and Effects of Tesamorelin, a Growth Hormone-releasing Factor Analogue, in HIV Pati
  Was treatment with tesamorelin generally well tolerated? Did tesamorelin produce sustained decreases in VAT and triglycerides?
AIDS
Category:   Articles > HIV/AIDS


2. Archbishop Tutu Urges US Senate to Pass AIDS Bill
  Archbishop Desmond Tutu of South Africa on Wednesday urged the U.S. Senate to pass a bill that would more than triple spending to fight AIDS, malaria and tuberculosis in Africa and other parts of the world. Reuters Health Information
Category:   Articles > HIV/AIDS


3. Study Offers New Clues to Effective HIV Vaccine
  Slight differences in five HLA amino acids may explain why certain people resist the human immunodeficiency virus, U.S. researchers said in a study that lends new clues about how to make an AIDS vaccine. Reuters Health Information
Category:   Articles > HIV/AIDS


4. Mifepristone Shows No Activity Against HIV
  The glucocorticoid receptor inhibitor mifepristone shows no significant activity against HIV, according to phase I/II trial results. Reuters Health Information
Category:   Articles > HIV/AIDS


5. Dose Reduction May Prevent Efavirenz Discontinuation in HIV Patients
  Efavirenz dose reduction is safe in HIV patients with high plasma concentrations and may prevent toxicity-induced discontinuations, Dutch researchers report in the October 1st issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS